Phase II study of chemoradiation therapy and erlotinib for stage Ill non-small cell lung cancer

被引：0
|
作者：
Komaki, Ritsuko U. [1 ]
Wistuba, Ignacio [1 ]
Tang, Xi Ming [1 ]
Meyn, Raymond E. [1 ]
Lee, J. Jack [1 ]
Wei, Xiong [1 ]
Allen, Pamela K. [1 ]
O'Reilly, Michael S. [1 ]
Welsh, James [1 ]
Hong, Wuan Ki [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-2658
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2658
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: A phase II study
    Baldini, E
    Silvano, G
    Tibaldi, C
    Campoccia, S
    Cionini, L
    Conte, P
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 28 - 32
  • [2] A prospective phase II study of induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong, Wenzhao
    Yang, Xuening
    Liao, Riqiang
    Nie, Qiang
    Su, Jian
    Chen, Zhihong
    Zhang, Xuchao
    An, Shejuan
    Zhou, Qing
    Yang, Jinji
    Wu, Yi Long
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Erlotinib in First-line Therapy for Non-small Cell Lung Cancer: A Prospective Phase II Study
    Choi, Dae Ro
    Lee, Dae Ho
    Choi, Chang-Min
    Kim, Sang-We
    Suh, Cheolwon
    Lee, Jung-Shin
    ANTICANCER RESEARCH, 2011, 31 (10) : 3457 - 3462
  • [4] Final Results of a Prospective Phase 2 Study of Adding Erlotinib to Chemoradiation for patients With Stage III Non-small Cell Lung Cancer
    Komaki, R. U.
    Allen, P. K.
    Wei, X.
    Blumenschein, G. R.
    XiMing, T.
    Lee, J. J.
    Welsh, J. W.
    Wistuba, I.
    Liu, D. D.
    Meyn, R.
    Hong, W. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E470 - E470
  • [5] Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study
    Stathopoulos, G. P.
    Trafalis, D.
    Dimitroulis, J.
    Athanasiou, A.
    Koutantos, J.
    Anagnostopoulos, A.
    ONCOLOGY LETTERS, 2010, 1 (02) : 335 - 338
  • [6] Phase II Study of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung Cancer
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Nukiwa, Toshihiro
    Mori, Kiyoshi
    Tsuboi, Masahiro
    Horai, Takeshi
    Masuda, Noriyuki
    Eguchi, Kenji
    Mitsudomi, Tetsuya
    Yokota, Soichiro
    Segawa, Yoshihiko
    Ichinose, Yukito
    Fukuoka, Masahiro
    Saijo, Nagahiro
    ANTICANCER RESEARCH, 2010, 30 (02) : 557 - 563
  • [7] A Phase I/II Study Combining Erlotinib andDasatinib for Non-Small Cell Lung Cancer
    Gold, Kathryn A.
    Lee, J. Jack
    Harun, Nusrat
    Tang, Ximing
    Price, Justina
    Kawedia, Jitesh D.
    Tran, Hai T.
    Erasmus, Jeremy J.
    Blumenschein, George R.
    William, Awilliam N.
    Wistuba, Ignacio I.
    Johnson, Faye M.
    ONCOLOGIST, 2014, 19 (10): : 1040 - 1041
  • [8] Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study
    Giaccone, Giuseppe
    Ruiz, Marielle Gallegos
    Le Chevalier, Thierry
    Thatcher, Nick
    Smit, Egbert
    Rodriguez, Jose Antonio
    Janne, Pasi
    Oulid-Aissa, Dalila
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6049 - 6055
  • [9] VALUE OF ADDING ERLOTINIB TO THORACIC RADIATION THERAPY WITH CHEMOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER: A PROSPECTIVE PHASE II STUDY
    Komaki, Ritsuko
    Allen, Pamela
    Wei, Xiong
    Blumen-Schein, George
    Tang, Xi Ming
    Lee, J. Lee J.
    Welsh, James W.
    Wistuba, Ignacio Ivan
    Liu, Diane D.
    Hong, Waun K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S136 - S137
  • [10] Chemoradiation for stage III non-small cell lung cancer
    Ramella, Sara
    Fiore, Michele
    Iurato, Aurelia
    Trodella, Luca E.
    Trodella, Lucio
    D'Angelillo, Rolando M.
    EUROPEAN JOURNAL OF ONCOLOGY, 2013, 18 (01): : 5 - 13
12345